317 related articles for article (PubMed ID: 17888421)
1. Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.
Ishizaki K; Iwaki T; Kinoshita S; Koyama M; Fukunari A; Tanaka H; Tsurufuji M; Sakata K; Maeda Y; Imada T; Chiba K
Eur J Pharmacol; 2008 Jan; 578(1):57-64. PubMed ID: 17888421
[TBL] [Abstract][Full Text] [Related]
2. Macrophage inflammatory protein-2 induced by TNF-alpha plays a pivotal role in concanavalin A-induced liver injury in mice.
Nakamura K; Okada M; Yoneda M; Takamoto S; Nakade Y; Tamori K; Aso K; Makino I
J Hepatol; 2001 Aug; 35(2):217-24. PubMed ID: 11580144
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide attenuates concanavalin A-mediated liver injury.
Luo Q; Wang Y; Feng D; Xu Y; Xu L
Eur J Pharmacol; 2009 Apr; 607(1-3):226-33. PubMed ID: 19222997
[TBL] [Abstract][Full Text] [Related]
4. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice.
Mizuhara H; Kuno M; Seki N; Yu WG; Yamaoka M; Yamashita M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
Hepatology; 1998 Feb; 27(2):513-9. PubMed ID: 9462651
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid receptor-dependent immunomodulatory effect of ursodeoxycholic acid on liver lymphocytes in mice.
Takigawa T; Miyazaki H; Kinoshita M; Kawarabayashi N; Nishiyama K; Hatsuse K; Ono S; Saitoh D; Seki S; Yamamoto J
Am J Physiol Gastrointest Liver Physiol; 2013 Sep; 305(6):G427-38. PubMed ID: 23868404
[TBL] [Abstract][Full Text] [Related]
6. Ursodeoxycholic acid (UDCA) suppresses liver interleukin 2 mRNA in the cholangitis model.
Miyaguchi S; Mori M
Hepatogastroenterology; 2005; 52(62):596-602. PubMed ID: 15816485
[TBL] [Abstract][Full Text] [Related]
7. The protective action of scutellarin against immunological liver injury induced by concanavalin A and its effect on pro-inflammatory cytokines in mice.
Tan ZH; Yu LH; Wei HL; Liu GT
J Pharm Pharmacol; 2007 Jan; 59(1):115-21. PubMed ID: 17227628
[TBL] [Abstract][Full Text] [Related]
8. The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFα-induced liver injury.
Pathil A; Warth A; Chamulitrat W; Stremmel W
J Hepatol; 2011 Apr; 54(4):674-84. PubMed ID: 21146893
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2
Hatano R; Kawaguchi K; Togashi F; Sugata M; Masuda S; Asano S
Biol Pharm Bull; 2017; 40(1):34-42. PubMed ID: 28049946
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
[TBL] [Abstract][Full Text] [Related]
11. Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity.
Buryova H; Chalupsky K; Zbodakova O; Kanchev I; Jirouskova M; Gregor M; Sedlacek R
BMC Gastroenterol; 2013 Oct; 13():155. PubMed ID: 24172289
[TBL] [Abstract][Full Text] [Related]
12. 1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α.
Jakubowski A; Sternak M; Jablonski K; Ciszek-Lenda M; Marcinkiewicz J; Chlopicki S
Int Immunopharmacol; 2016 Feb; 31():98-104. PubMed ID: 26709075
[TBL] [Abstract][Full Text] [Related]
13. Effect of diphenyl dimethyl bicarboxylate on concanavalin A-induced liver injury in mice.
Gao M; Zhang J; Liu G
Liver Int; 2005 Aug; 25(4):904-12. PubMed ID: 15998443
[TBL] [Abstract][Full Text] [Related]
14. [Preventive administration of new UDCA derivatives in experimental alcoholic steatohepatitis].
Belonovskaia EB; Naruta EE; Lukivskaia OIa; Abakumov VZ; Buko VU
Eksp Klin Farmakol; 2013; 76(1):25-9. PubMed ID: 23461012
[TBL] [Abstract][Full Text] [Related]
15. Redundant function of macrophage inflammatory protein-2 and KC in tumor necrosis factor-alpha-induced extravasation of neutrophils in vivo.
Zhang XW; Wang Y; Liu Q; Thorlacius H
Eur J Pharmacol; 2001 Sep; 427(3):277-83. PubMed ID: 11567658
[TBL] [Abstract][Full Text] [Related]
16. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10.
Fukuda T; Hisadome M; Komatsu H
J Pharm Pharmacol; 2005 Nov; 57(11):1461-6. PubMed ID: 16259779
[TBL] [Abstract][Full Text] [Related]
17. A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury.
Ishida Y; Kondo T; Ohshima T; Fujiwara H; Iwakura Y; Mukaida N
FASEB J; 2002 Aug; 16(10):1227-36. PubMed ID: 12153990
[TBL] [Abstract][Full Text] [Related]
18. Leflunomide protects from T-cell-mediated liver injury in mice through inhibition of nuclear factor kappaB.
Imose M; Nagaki M; Kimura K; Takai S; Imao M; Naiki T; Osawa Y; Asano T; Hayashi H; Moriwaki H
Hepatology; 2004 Nov; 40(5):1160-9. PubMed ID: 15455409
[TBL] [Abstract][Full Text] [Related]
19. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
[TBL] [Abstract][Full Text] [Related]
20. Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice.
Xu X; Hu Y; Zhai X; Lin M; Chen Z; Tian X; Zhang F; Gao D; Ma X; Lv L; Yao J
Toxicol Appl Pharmacol; 2013 Nov; 273(1):68-76. PubMed ID: 23993977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]